Summary
This 8-K/A filing from UnitedHealth Group Inc. (UNH) provides an amendment related to the compensation arrangements for Mr. Rex, a key executive. Specifically, it details the approval of his annual base salary, cash incentive award, and various stock-based awards by the Compensation and Human Resources Committee. These updates offer clarity on the remuneration structure for a senior member of the management team, which is a crucial aspect for investors to understand executive incentives and potential future share dilution. The approved compensation includes a base salary of $1,400,000, with a target annual cash incentive award of 200% of his base salary. Furthermore, Mr. Rex received significant stock awards, comprising stock options valued at $150,000, restricted stock units (RSUs) valued at $150,000, and performance shares valued at $300,000. These elements are designed to align executive compensation with company performance and shareholder value, providing insights into how the company retains and motivates its top talent.
Key Highlights
- 1Amendment to a previous filing concerning executive compensation.
- 2Compensation for Mr. Rex, a key officer, has been updated.
- 3Annual base salary for Mr. Rex set at $1,400,000.
- 4Target annual cash incentive award opportunity is 200% of base salary.
- 5Stock awards granted to Mr. Rex include: stock options ($150,000 value), restricted stock units ($150,000 value), and performance shares ($300,000 value).
- 6The Compensation and Human Resources Committee approved these new compensation arrangements.